Capital Genomix, Inc.

Capital Genomix (CGI) is a genomic company that is presently developing a gene analysis platform, GeneSystem320™, which provides a rapid alternative method to chip technology for detailed gene expression analysis and discovery. This system enables the analysis of virtually any gene or set of genes using a defined set of reagents including 320 PCR™ primers. The company also has a cDNA Integrity Kit that offers an accurate means to evaluate cDNA preparations to determine the presence of full-length and extended transcripts prior to their use. Results can be obtained from any single or double-stranded cDNA synthesized from human, mouse, or rat cells and tissue. Capital Genomix, Inc. and KPL (Gaithersburg, MD) have a marketing alliance to bring the GeneSystem320 product line to the life science researchers.